Drug Discovery News
-
Rock Creek granted Japanese, European, US Patent for lead compound
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 May, 2016
Rock Creek Pharmaceuticals Inc, a clinical-stage drug development company focused on the application of its lead compoun...Read more
-
Infect mosquitoes with Wolbachia, stop diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Apr, 2013
Singapore: Scientists at Melbourne University and University of California have found that mosquito that are infected wi...Read more
-
LabCorp launches 4th gen HIV antigen assay
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Nov, 2013
Singapore: Laboratory Corporation of America has released 4th generation HIV antigen/antibody combination assay and a ne...Read more
-
FDA designates Chugai's bispecific antibody as breakthrough therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2015
Japan's pharma giant, Chugai Pharmaceutical Co. has reported that the US Food and Drug Administration (FDA) has granted ...Read more
-
NZ gets drug that glows brain tumour
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Sep, 2015
Singapore: A novel drug, GLIOLAN (aminolevulinic acid HCl), that helps neurosurgeons to better visualise and remove mali...Read more
-
Singapore develops animal-free screening platform to predict nephrotoxicity
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2015
Singapore: Researchers from Singapore's Institute of Bioengineering and Nanotechnology (IBN) have developed an animal-fr...Read more
-
Shionogi's constipation drug phase III study shows significant improvement
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2016
The US subsidiary of Osaka-based Shionogi has announced results of its pivotal phase III study (COMPOSE I). The study re...Read more
-
LBT Innovations inks partnership with French tech firm
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2015
Singapore: Australian medical technology company, LBT Innovations, has signed a license agreement with French in vitro d...Read more
-
CARsgen partners with Shanghai Cancer Institute to develop cancer immunotherapies
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Sep, 2015
Singapore: China based CARsgen Therapeutics, a private and venture backed company focused on the development of CAR-T-ba...Read more
-
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2014
Singapore: Actavis has recieved US Federal Trade Commission (FTC) nod to acquire Forest Laboratories following a propose...Read more
-
Phylogica appoints CEO, CSO, CFO
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: Leading Australian peptide drug discovery company Phylogica appointed Dr Richard Hopkins as the company's new...Read more
-
Kowa Pharma and Eli Lilly release PK study result
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2012
Singapore: Kowa Pharmaceuticals and Eli Lilly released results from a pharmacokinetic (PK) study exploring potential dru...Read more
-
TWi's diabetes drug recieves patent allowance from Europe, Russia
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2015
Singapore: Taiwan based TWi Biotechnology has received patent allowance for AC-201, its lead drug candidate, from the Eu...Read more
-
Japanese stem cell company ReproCELL acquires Biopta
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Nov, 2015
Tokyo: Japanese regenerative medicine company ReproCELL Inc. has announced the acquisition of the Scottish life science...Read more
-
IBM, A*Star co-develop anti-microbial hydrogel
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jan, 2013
Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-e...Read more
-
Pfizer launches targeted therapy for lung cancer in Singapore
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2015
Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singa...Read more
-
HSA nod for Aslan rheumatoid arthritis drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013
Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Tri...Read more
-
Celsion launches cancer drug trial in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2016
Singapore: Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovat...Read more
